| P50 | author | Paul Glue | Q30668714 |
| | Peter Herbison | Q55950471 |
| P2093 | author name string | Greg P Tarr | |
| P2860 | cites work | An assessment of clinically useful measures of the consequences of treatment | Q28297274 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | Treatment of bipolar disorder: a systematic review of available data and clinical perspectives | Q33364302 |
| | A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 |
| | Bipolar disorder | Q80392074 |
| | Clinical correlates of therapeutic response in bipolar disorder | Q34547113 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | Treatment guidelines for bipolar disorder: a critical review. | Q36093544 |
| | The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. | Q36192638 |
| | Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials | Q36466463 |
| | Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials | Q36778511 |
| | Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials | Q36936379 |
| | A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia | Q37327871 |
| | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 |
| | Olanzapine versus divalproex versus placebo in the treatment of mild to moderate mania: a randomized, 12-week, double-blind study. | Q38385608 |
| | The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale | Q41529197 |
| | A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states | Q43258938 |
| | Olanzapine versus divalproex in the treatment of acute mania | Q44013092 |
| | Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study | Q44159999 |
| | A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder | Q44275529 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Olanzapine compared to lithium in mania: a double-blind randomized controlled trial | Q46146139 |
| | Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study | Q46178044 |
| | Risperidone in the treatment of acute mania: double-blind, placebo-controlled study | Q46681460 |
| | Response and remission rates in Chinese patients with bipolar mania treated for 4 weeks with either quetiapine or lithium: a randomized and double-blind study | Q46889468 |
| | Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. | Q51903227 |
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | meta-analysis | Q815382 |
| | systematic review | Q1504425 |
| P304 | page(s) | 14-19 | |
| P577 | publication date | 2011-11-01 | |
| P1433 | published in | Journal of Affective Disorders | Q15716493 |
| P1476 | title | Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania — A systematic review and meta-analysis | |
| P478 | volume | 134 | |